Ligand Pharmaceuticals (LGND)
NASDAQ: LGND
· Real-Time Price · USD
151.31
-2.48 (-1.61%)
At close: Aug 15, 2025, 3:44 PM
-1.61% (1D)
| Bid | 151.2 |
| Market Cap | 2.97B |
| Revenue (ttm) | 187.58M |
| Net Income (ttm) | -75.86M |
| EPS (ttm) | -4.04 |
| PE Ratio (ttm) | -37.45 |
| Forward PE | 21.29 |
| Analyst | Buy |
| Ask | 151.9 |
| Volume | 190,514 |
| Avg. Volume (20D) | 201,214 |
| Open | 155.28 |
| Previous Close | 153.79 |
| Day's Range | 150.99 - 155.28 |
| 52-Week Range | 93.58 - 157.54 |
| Beta | 0.74 |
About LGND
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LGND
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LGND stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Ligand Pharmaceuticals has released their quartely earnings
on Aug 7, 2025:
Next Earnings Release
Ligand Pharmaceuticals is scheduled to release its earnings on
Nov 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago
+0.57%
Ligand Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
9 months ago
+11.12%
Ligand Pharmaceuticals shares are trading higher after the company reported worse-than-expected Q3 financial results and raised its FY24 guidance.
